Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127567541 | 12756754 | 1 | I | 20160815 | 20160905 | 20160917 | 20160917 | EXP | IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-123813 | RANBAXY | 79.08 | YR | F | Y | 0.00000 | 20160917 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127567541 | 12756754 | 1 | SS | MIRTAZAPINE. | MIRTAZAPINE | 1 | Oral | 1 DOSAGE 1 DF DAILY | U | U | 0 | 1 | DF | ||||||
| 127567541 | 12756754 | 2 | PS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | 1 DOSAGE 50 MG DAILY | U | U | 77977 | 50 | MG | ||||||
| 127567541 | 12756754 | 3 | SS | SONGAR 0,375 MG/ML | TRIAZOLAM | 1 | Oral | 1 DOSAGE 16 GTT DAILY | U | U | 0 | 16 | GTT | ||||||
| 127567541 | 12756754 | 4 | C | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | Oral | UNK | U | U | 0 | ||||||||
| 127567541 | 12756754 | 5 | C | ISOPTIN 40 MG | 2 | Oral | UNK | U | U | 0 | |||||||||
| 127567541 | 12756754 | 6 | C | CLEXANE 4000 U.I. | 2 | Subcutaneous | UNK | U | U | 0 | |||||||||
| 127567541 | 12756754 | 7 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG | U | U | 0 | 40 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127567541 | 12756754 | 1 | Depression |
| 127567541 | 12756754 | 2 | Depression |
| 127567541 | 12756754 | 3 | Depression |
| 127567541 | 12756754 | 4 | Product used for unknown indication |
| 127567541 | 12756754 | 5 | Product used for unknown indication |
| 127567541 | 12756754 | 6 | Product used for unknown indication |
| 127567541 | 12756754 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127567541 | 12756754 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127567541 | 12756754 | Dysarthria | |
| 127567541 | 12756754 | Sopor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127567541 | 12756754 | 1 | 20160101 | 20160815 | 0 | |
| 127567541 | 12756754 | 2 | 20160101 | 20160815 | 0 | |
| 127567541 | 12756754 | 3 | 20160101 | 20160815 | 0 |